US HB4669 | 2015-2016 | 114th Congress
Status
Spectrum: Partisan Bill (Democrat 2-0)
Status: Introduced on March 2 2016 - 25% progression, died in committee
Action: 2016-03-04 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on March 2 2016 - 25% progression, died in committee
Action: 2016-03-04 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Advancing Standards in Regenerative Medicine Act This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to facilitate the establishment of a public-private Standards Coordinating Body in Regenerative Medicine and Advanced Therapies. The FDA must work with this body to develop standards to support the development and review of regenerative medicine products.
Title
Advancing Standards in Regenerative Medicine Act
Sponsors
| Rep. Bill Foster [D-IL] | Rep. Tim Ryan [D-OH] |
History
| Date | Chamber | Action |
|---|---|---|
| 2016-03-04 | House | Referred to the Subcommittee on Health. |
| 2016-03-02 | House | Referred to the House Committee on Energy and Commerce. |
| 2016-03-02 | House | Introduced in House |
Same As/Similar To
SB2443 (Same As) 2016-01-12 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Subjects
Cell biology and embryology
Drug safety, medical device, and laboratory regulation
Genetics
Health
Medical research
Organ and tissue donation and transplantation
Public-private cooperation
Drug safety, medical device, and laboratory regulation
Genetics
Health
Medical research
Organ and tissue donation and transplantation
Public-private cooperation
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/114th-congress/house-bill/4669/all-info |
| Text | https://www.congress.gov/114/bills/hr4669/BILLS-114hr4669ih.pdf |
